Here's a breakdown of the 2025 clinical trials related to cannabis and cancer, based on the provided information.
The provided information highlights several ongoing clinical trials in 2025 exploring the potential of cannabinoids in cancer treatment. These trials are geographically diverse, spanning the United States, Israel, Australia, and Spain. The focus areas include glioblastoma, triple-negative breast cancer, and pancreatic cancer. It's crucial to note the accompanying caution from the FDA and NCI regarding claims of cannabis curing cancer, emphasizing that while promising evidence is emerging, clinical validation is still in progress.
According to www.iAsk.Ai - Ask AI:
The trials mentioned are:
- U.S. & Israel: Phase II glioblastoma trials testing CBD-THC combinations.
- Australia: CBD for triple-negative breast cancer.
- Spain: Cannabinoid receptor activation in pancreatic cancer.
The FDA and NCI caution against claims of cannabis curing cancer, but promising adjunctive evidence is growing, and clinical validation is ongoing.
Authoritative Sources
- Clinical Trials Information. [ClinicalTrials.gov]↩
- National Cancer Institute. [National Cancer Institute]↩
- U.S. Food & Drug Administration. [U.S. Food & Drug Administration]↩
Answer Provided by iAsk.ai – Ask AI.
Sign up for free to save this answer and access it later
Sign up →